share_log

華領醫藥-B：(I)建議重選退任董事；(II)建議授出回購股份及發行股份之一般授權；(III)建議續聘核數師；(IV)建議採納新組織章程大綱及細則；及(V)股東週年大會通告

HUA MEDICINE-B: (I) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (II) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (III) PROPOSED RE-APPOINTMENT OF AUDITOR; (IV) PROPOSED ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (V) NOT

Hong Kong Stock Exchange ·  Apr 25 05:30
Summary by Moomoo AI
華領醫藥-B（股份代號：2552）將於2024年6月27日在上海總部召開股東週年大會，會議將討論重選退任董事、授出回購股份及發行股份之一般授權、續聘核數師及採納新組織章程大綱及細則等議題。股東若無法出席，需於會議前48小時提交代表委任表格。此外，公司亦建議修訂組織章程細則，以符合最新的上市規則。股東大會的投票結果將按規定公布於公司及香港交易所的網站。
華領醫藥-B（股份代號：2552）將於2024年6月27日在上海總部召開股東週年大會，會議將討論重選退任董事、授出回購股份及發行股份之一般授權、續聘核數師及採納新組織章程大綱及細則等議題。股東若無法出席，需於會議前48小時提交代表委任表格。此外，公司亦建議修訂組織章程細則，以符合最新的上市規則。股東大會的投票結果將按規定公布於公司及香港交易所的網站。
HUALEN PHARMACEUTICAL-B (SHARE CODE: 2552) WILL HOLD ITS ANNUAL GENERAL MEETING AT ITS SHANGHAI HEADQUARTERS ON 27 JUNE 2024 TO DISCUSS THE RE-ELECTION OF RETIRING DIRECTORS, GRANTING GENERAL MANDATES TO REPURCHASE SHARES AND ISSUE SHARES, REAPPOINTMENT OF AUDITORS AND ADOPTION OF A NEW CHARTER AND RULES OF ORGANIZATION. If shareholders are unable to attend, a proxy form must be submitted 48 hours prior to the meeting. In addition, the Company also proposes to amend the Articles of Association to comply with the latest listing rules. The voting results of the General Meeting will be published as required on the Company's and HKEX's websites.
HUALEN PHARMACEUTICAL-B (SHARE CODE: 2552) WILL HOLD ITS ANNUAL GENERAL MEETING AT ITS SHANGHAI HEADQUARTERS ON 27 JUNE 2024 TO DISCUSS THE RE-ELECTION OF RETIRING DIRECTORS, GRANTING GENERAL MANDATES TO REPURCHASE SHARES AND ISSUE SHARES, REAPPOINTMENT OF AUDITORS AND ADOPTION OF A NEW CHARTER AND RULES OF ORGANIZATION. If shareholders are unable to attend, a proxy form must be submitted 48 hours prior to the meeting. In addition, the Company also proposes to amend the Articles of Association to comply with the latest listing rules. The voting results of the General Meeting will be published as required on the Company's and HKEX's websites.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more